Vertex Pharmaceuticals announced the FDA has accepted its biologics license application submission for povetacicept, an ...

Voyxact helped preserve kidney function, but left an opening for competing IgAN drugs from Vera and Vertex. Elsewhere, Takeda ...

(Reuters) - As cholesterol fighter Lipitor goes generic, its maker Pfizer Inc is hoping to hold onto perhaps a third of the 3 million Americans who take the biggest-selling drug of all time. Lipitor, ...

Pfizer announced yesterday it was settling an epic legal battle with the Indian drugmaker Ranbaxy Laboratories that will keep generic versions of the best-selling cholesterol medicine Lipitor off the ...

Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced the launch of Tofacitinib Tablets, ...

TORONTO/NEW YORK (Reuters) - Apotex Inc said on Wednesday it would immediately launch in Canada a copycat form of Pfizer Inc's blockbuster Lipitor cholesterol fighter, and Pfizer vowed to fight back ...

FILE - In this June 14, 2011 file photo, the drug Lipitor is displayed at Medco Health Solutions Inc., in Willingboro, N.J. Cholesterol blockbuster Lipitor is so valuable to Pfizer Inc. that the drug ...

Pfizer and its partners have granted Rigel Pharmaceuticals an exclusive license to commercialize VEPPANU (vepdegestrant), the first FDA approved oral PROTAC for advanced breast cancer. The agreement ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...